158 related articles for article (PubMed ID: 23866362)
1. Pharmacogenetics and personalised medicine: maintain a critical approach.
Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic application in personalized cancer treatment.
Kristyanto H; Utomo AR
Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
[TBL] [Abstract][Full Text] [Related]
3. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
4. Large personalised medicine trial in lung cancer heralds new research partnership.
Torjesen I
BMJ; 2014 Apr; 348():g2837. PubMed ID: 24742663
[No Abstract] [Full Text] [Related]
5. Individualized drug therapy.
Daly AK
Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
[TBL] [Abstract][Full Text] [Related]
6. Personalised medicine in the genome era.
Chalmers D; Nicol D; Otlowski M; Critchley C
J Law Med; 2013 Mar; 20(3):577-94. PubMed ID: 23600190
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment and pharmacogenetics in molecular and genomic epidemiology.
Park SK; Choi JY
J Prev Med Public Health; 2009 Nov; 42(6):371-6. PubMed ID: 20009483
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and anaesthesia: the value of genetic profiling.
Landau R; Bollag LA; Kraft JC
Anaesthesia; 2012 Feb; 67(2):165-79. PubMed ID: 22251108
[TBL] [Abstract][Full Text] [Related]
9. Infusion of pharmacogenetics into cancer care.
Prows CA
Semin Oncol Nurs; 2011 Feb; 27(1):45-53. PubMed ID: 21255712
[TBL] [Abstract][Full Text] [Related]
10. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenetic aspects of current pharmacotherapy].
Slanar O; Zima T
Cas Lek Cesk; 2010; 149(10):472-5. PubMed ID: 21121137
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of pharmacogenomics/biomarker-guided clinical trials for regulatory approval of anti-cancer drugs in Japan.
Ishiguro A; Yagi S; Uyama Y
J Hum Genet; 2013 Jun; 58(6):313-6. PubMed ID: 23657427
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of asthma.
Pascual RM; Bleecker ER
Curr Opin Pharmacol; 2010 Jun; 10(3):226-35. PubMed ID: 20646961
[TBL] [Abstract][Full Text] [Related]
16. Application of genotype-guided cancer therapy in solid tumors.
Patel JN
Pharmacogenomics; 2014 Jan; 15(1):79-93. PubMed ID: 24329193
[TBL] [Abstract][Full Text] [Related]
17. Population-based differences in treatment outcome following anticancer drug therapies.
Ma BB; Hui EP; Mok TS
Lancet Oncol; 2010 Jan; 11(1):75-84. PubMed ID: 20129130
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
19. Where are we today with personalized medicine?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
[TBL] [Abstract][Full Text] [Related]
20. Personalised medicine for cancer: from drug development into clinical practice.
Jain KK
Expert Opin Pharmacother; 2005 Aug; 6(9):1463-76. PubMed ID: 16086635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
